Recombinant human thyrotropin thyroid hormone withdrawal in differentiated thyroid carcinoma follow-up: a single center experience.

Journal: Acta endocrinologica (Bucharest, Romania : 2005)
Published Date: Jan 1, 2021

Abstract

INTRODUCTION: Our goal was to evaluate and compare the diagnostic utility of thyroid hormone withdrawal (THW) and recombinant thyroid-stimulating hormone (rhTSH) methods in detecting recurrence/persistence (R/PD) of differentiated thyroid carcinoma (DTC).

Authors

  • M Sahin
    Ankara University, Faculty of Medicine - Department of Endocrinology and Metabolism, Ankara, Turkey.
  • B I Aydoğan
    Ankara University, Faculty of Medicine - Department of Endocrinology and Metabolism, Ankara, Turkey.
  • E Özkan
    Ankara University, Faculty of Medicine - Department of Nuclear Medicine, Ankara, Turkey.
  • R Emral
    Ankara University, Faculty of Medicine - Department of Endocrinology and Metabolism, Ankara, Turkey.
  • S Güllü
    Ankara University, Faculty of Medicine - Department of Endocrinology and Metabolism, Ankara, Turkey.
  • M F Erdogan
    Ankara University, Faculty of Medicine - Department of Endocrinology and Metabolism, Ankara, Turkey.
  • D Çorapçıoğlu
    Ankara University, Faculty of Medicine - Department of Endocrinology and Metabolism, Ankara, Turkey.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals